Navigation Links
ISPE Patient Initiative Issues Survey Regarding Patient Experience with Clinical Materials
Date:6/10/2013

e goals of the study are to provide information and analysis that will:

  • Foster an understanding of patient experiences with IPs to support informed decisions around future design and management of study materials, leading to more efficient and effective studies as well as enhancing patient compliance.
  • Help the industry discern the impact of key differentiators on the patient experience with IPs, equipping professionals with information to determine when adjustments are needed to ensure the highest level of patient protocol compliance.

The study has been made possible by the generous support of eleven underwriting companies. Their investment in the mission and work of ISPE has allowed the task force to design and carry out this comprehensive project to the ultimate benefit patients around the world. ISPE wishes to thank the underwriters including:

  • Almac Clinical Services
  • Boehringer Ingelheim Pharma GMBH & Co.
  • Catalent Pharma Solutions
  • Cenduit LLC
  • Merck Sharp & Dohme Corporation
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • PAREXEL International
  • Pfizer Inc.
  • Takeda Global Research & Development Centre (Europe), Ltd
  • UCB Pharma S.A.

 "Ensuring that clinical trials are as successful as they can possibly be constitutes a win for all ISPE stakeholders," says Berg. "Moreover, in the future we believe that the experience of the patient will and should have a bigger impact on cGMP decisions concerning clinical materials. This survey is a critical first step."

An update on the study will occur 13 June 2013 at ISPE's Conference "World-Class Supply End-to-End" in Prague, Czech Republic. On that date and thereafter, ISPE will host a website section devoted to it
'/>"/>

SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... NEW YORK , March 5, 2015 /PRNewswire/ ... evolving set of regulations, Ethics & Compliance professionals ... according to a new survey issued today by ... services and education. An overwhelming majority of respondents ... far the most important component of E&C training ...
(Date:3/5/2015)... , March 5, 2015 CANTEL MEDICAL CORP. ... its second quarter ended January 31, 2015 on Thursday, March ... to discuss the results at 11:00 AM ET. ... approximately 5 to 10 minutes before the beginning of the ... of the call will be available from Thursday, March 12, ...
(Date:3/5/2015)... 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), a ... state-of-the-art, automated DNA-based molecular analyses, announces that it ... which utilizes cutting edge technology, including next- generation ... 12,000 women are diagnosed with cervical cancer in ... Human Papillomaviruses (HPV) are a group of more ...
Breaking Medicine Technology:Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... Loss, Non-Inferiority in Target Vessel Failure and Low Rates of MACE ... ... PARK, Ill., April 22 A study published,in today,s Journal of ... Everolimus Eluting Coronary Stent System,in patients with coronary artery disease resulted ...
... April 22 , - Summary: Using Protein ... Mode of Action of Humax- EGFr,(Zalutumumab). In This ... That,Zalutumumab Locks the EGFr Into a Very Compact ... Growth., Sidec AB announced today that together ...
Cached Medicine Technology:Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS 2
(Date:3/5/2015)... At the 7th Annual Mississippi ... addiction treatment met today in Jackson, Mississippi to listen ... Among the numerous respected speakers will be William ... role that pain medications have had in today’s opiate ... , "It is hard to believe that much of ...
(Date:3/5/2015)... 05, 2015 Califia Farms , ... at Natural Products Expo West that its popular ready-to-drink ... percent soy and dairy free. Califia Farms Vegan Protein ... and are packed with six grams of an innovative ... fiber, B vitamins and magnesium. , Protein is an ...
(Date:3/5/2015)... 2015 University of Western States ... 1904, has launched a new center of excellence ... The Northwest Center for Lifestyle and Functional Medicine ... outreach, and conduct research in the areas of ... nutrition. The center will target efforts on the ...
(Date:3/5/2015)... 05, 2015 Supply & Demand Chain ... of “Pros to Know” in the supply chain industry, ... of MEBC’s leadership team were included on this year’s ... received this award due to their hard work, their ... for meeting and resolving client needs and challenges. ...
(Date:3/5/2015)... Dr. Jonathan Glashow a board certified New ... named by Castle Connolly as a Top ... has been selected by Castle Connolly Medical Ltd. for ... care doctors in the tri-state metropolitan New York area ... carefully screens and selects doctors through a rigorous peer ...
Breaking Medicine News(10 mins):Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2
... , , , ... month that the first recipients enrolled in Medicare. Now is the time ... for all," said Dr. Jane L. Delgado, President and CEO of the National ... , , "President Obama set out in his ...
... Evidence That Criticisms Are Registering As Debate Intensifies , ... Congress works through specific health reform proposals, the July Kaiser Health Tracking Poll ... reform now, though there is some softening of support as criticisms and doubts ... been the case over the past ten months, a majority of the American ...
... 28th Annual KLOS Blood Drive Aims ... LOS ANGELES, July 22 The American Red Cross and 95.5 KLOS ... Blood Drive. The 2009 KLOS Blood Drive will run for five days, ... and classic rock fans are encouraged to donate at any of the 19 ...
... , INCLINE VILLAGE, Nev., July 22 PDL BioPharma, ... hold a conference call and webcast on Thursday, July 30 at 4:30 p.m. ... and provide a business update. The call and webcast will follow the release ... , , Conference Call Details , ...
... shows devices contain carcinogens, other toxins , WEDNESDAY, ... cigarettes, known as e-cigarettes, has shown that they ... compound used in antifreeze, U.S. health officials said ... cartridges filled with nicotine, flavorings and other chemicals. ...
... WASHINGTON, July 22 There are many provisions in ... care greatly about the freedom to choose their health care. Some of ... * Eliminates Existing Private Insurance Coverage (i.e., Eliminates Your Choice ... But Is Just Fine With You and Your Family) , ...
Cached Medicine News:Health News:Time to Get the Job Done Says Alliance President and CEO 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 2Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 3Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 4Health News:Majority of Public Maintains Support for Addressing Health Care Reform Now 5Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 2Health News:KLOS & Red Cross Set to Rock SoCal With Massive 5 Day Blood Drive 3Health News:PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 2Health News:E-Cigarettes Pose a Health Hazard, FDA Warns 3Health News:Mandate for Health Insurance: Inconvenient Truths About How It Will Affect You and Your Family 2
... The Benchtop Fume Hood is an economical ... in which a number of fume hoods ... junior colleges and universities. Features include a ... with rounded inside corners for easy cleaning. ...
These handy dispensers save space and organize gloves in labs and next to hand washers. Clear acrylic. Many other sizes and custom configurations available....
... most convenient for sectioning of specimens in ... Specimen rise is automatic and accurate with ... microns in increments of 0.5 microns. ... Products, Vibratomes Freezing Stages ...
... MNL 440601 Small Sledge Microtome is ideal for ... or skin specimens. Specimen rise is automatic ... 30 microns in increments of 2 microns. ... Stages.,Other Associated Products, Vibratomes Freezing Stages ...
Medicine Products: